Amarin reported $-5144000 in Operating Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
DBV Technologies DBVT:US USD -18020000 5.8M
Abbvie ABBV:US USD 4.6B 1.31B
Alnylam Pharmaceuticals ALNY:US USD -334626000 142.94M
Amarin AMRN:US USD -5144000 57.69M
AstraZeneca AZN:LN USD 1.25B 706M
Biocryst Pharmaceuticals BCRX:US USD -17445000 17.28M
Esperion Therapeutics ESPR:US USD -41623000 10.75M
GlaxoSmithKline GSK:LN GBP 1.87B 677M
Halozyme Therapeutics HALO:US USD 80.58M 46.52M
Heron Therapeutics HRTX:US USD -41882000 7.62M
Intercept Pharmaceuticals ICPT:US USD -101903000 88.54M
IONIS PHARMACEUT IONS:US USD -59154000 26.36M
JAZZ PHA JAZZ:US USD 24.76M 60.78M
Nektar Therapeutics NKTR:US USD -54301000 98.54M
Neurocrine Biosciences NBIX:US USD 87.8M 103.1M
Novartis NOVN:VX USD 2.17B 60M
Teva Pharmaceutical Industries TEVA:US USD 419M 1.37B